Medidata plans Mass. blitz

Talk about heading into enemy territory: CTMS solutions maker Medidata, flanked by Almac Clinical Technologies (interactive voice and web response technology) and PHT (electronic patient-reported outcome solutions), journeys to Waltham, MA, later this week on a two-stop tour of breakfast seminars on leveraging clinical trial data. The focus is the Almac/PHT/Medidata data-integration approach for viewing patient data in one system. Waltham, of course, is the seat of power for CTMS archrivals Phase Forward, Perceptive Informatics, and Akaza Research. Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.